Publication
Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Journal Paper/Review - Jul 6, 2010
Lugli Alessandro, Terracciano L, Spagnoli G, Carafa Vincenza, Tornillo Luigi, Mele V, Muraro M G, Hostettler Isabel, Iezzi Giandomenica, Zlobec Inti
Units
PubMed
Doi
Contact
Citation
Lugli A, Terracciano L, Spagnoli G, Carafa V, Tornillo L, Mele V, Muraro M, Hostettler I, Iezzi G, Zlobec I. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. Br J Cancer 2010; 103:382-90.
Type
Journal Paper/Review (English)
Journal
Br J Cancer 2010; 103
Publication Date
Jul 6, 2010
Issn Electronic
1532-1827
Pages
382-90
Brief description/objective
The aim of this study was to elucidate the prognostic impact of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and aldehyde dehydrogenase-1 (ALDH1) in colorectal cancer.